Skip to main content

Find Clinical Trials

Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

490 public trials 154 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Recruiting

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

NCT06340646

Conditions: Adenocarcinoma, Blood Protein Disorders, Carcinoma, +30 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT06282575

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +11 more
Locations: City of Hope(City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States

Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States

AdventHealth Hematology and Oncology Orlando, Florida, United States

Winship Cancer Institute Atlanta, Georgia, United States

View all 185 locations

View Trial Details

Recruiting

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

NCT05874414

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +10 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

LACN Aneheim Flagship Office Los Angeles, California, United States

Orlando Health Orlando, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

NCT03942328

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

NCT05286814

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +33 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

TCR1188-ABC Cells in KRAS-mutated Cancers

NCT07594067

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +24 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

NCT06342414

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

Graduate School of Medical Sciences, Kyushu University Fukuoka, Japan

Graduate School of Medical Sciences, Kumamoto University Kumamoto, Japan

Hokkaido University Graduate School of Medicine Sapporo, Japan

View Trial Details

Recruiting

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

NCT07337525

Conditions: Adenocarcinoma, Advanced Malignant Solid Tumor, Carcinoma, +21 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

NEXT Dallas Dallas, Texas, United States

MD Anderson Cancer Center Houston, Texas, United States

NEXT Houston Houston, Texas, United States

View Trial Details

Recruiting

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

NCT07224750

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations: City of Hope Nat Medical Ctr Duarte, California, United States

View Trial Details

Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Stanford University Medical Center Stanford, California, United States

Biogenix Molecular, LLC Miami, Florida, United States

Moffitt Tampa, Florida, United States

View all 30 locations

View Trial Details